Loading…
US stock · US markets · public data
UTHR
United Therapeutics Corp · Healthcare
Reference price$475.45Updated according to the public source
P/E17.01
P/B3.17
ROE19.32%
DY 12M—
Net margin41.56%
Debt/equity—
Market capUS$ 20.4 B
Volume (shares)555,480
SectorHealthcare
Overview
Indicadores públicos consolidadosAbout UTHR
United Therapeutics Corp (UTHR) is a stock traded in US markets in the Healthcare sector. P/E 17.01, P/B 3.17, ROE 19.32% and dividend yield not disclosed. The P/E multiple helps compare this asset's valuation with other companies in the same sector. Explore the public market data tracked by FundamentalRadar. This page includes key fundamental indicators, recent distributions and financial statements available from the public sources tracked by FundamentalRadar.
Distributions
public dataDividends and distributions · last 12 records
The source returned no recent distributions for this asset.
Financials
No dataIncome statement, balance sheet and cash flow
Financial statements are not available for this asset yet.
FAQ
Frequently asked questions
What is the price of UTHR?
The current price of UTHR is $475.45.
What is the P/E of UTHR?
The P/E ratio of UTHR is 17.01, meaning investors pay 17.01 times earnings per share.
What is the P/B of UTHR?
The P/B of UTHR is 3.17, meaning the stock trades at 3.17 times its book value per share.
What is the ROE of UTHR?
The ROE (Return on Equity) of UTHR is 19.32%, meaning the company generates 19.32% of profit for every unit of shareholders' equity.
What is the market cap of UTHR?
The market capitalization of UTHR is US$ 20.4 B.
What is the net margin of UTHR?
The net profit margin of UTHR is 41.56%, meaning the company keeps 41.56% of revenue as profit.
What sector is UTHR in?
UTHR operates in the Healthcare sector.